Iron metabolism as a novel therapeutic target
- PMID: 34854879
- DOI: 10.1182/blood.2021013086
Iron metabolism as a novel therapeutic target
Comment on
-
CYB561A3 is the key lysosomal iron reductase required for Burkitt B-cell growth and survival.Blood. 2021 Dec 2;138(22):2216-2230. doi: 10.1182/blood.2021011079. Blood. 2021. PMID: 34232987 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical

